1133P Whole genome sequencing can classify diagnostically challenging tumors.

MLA

Schipper, L. J., et al. “1133P Whole Genome Sequencing Can Classify Diagnostically Challenging Tumors.” Annals of Oncology, vol. 32, Sept. 2021, pp. S924–25. EBSCOhost, https://doi.org/10.1016/j.annonc.2021.08.775.

APA

Schipper, L. J., Snaebjornsson, P., Samsom, K. G., Bosch, L. J. W., Lalezari, F., Priestley, P., Shale, C., Jacobs, N., van den Broek, A. J., Roepman, P., van der Hoeven, J. J. M., Steeghs, N., Cuppen, E., Meijer, G., Voest, E. E., & Monkhorst, K. (2021). 1133P Whole genome sequencing can classify diagnostically challenging tumors. Annals of Oncology, 32, S924–S925. https://doi.org/10.1016/j.annonc.2021.08.775

Chicago

Schipper, L.J., P. Snaebjornsson, K.G. Samsom, L.J.W. Bosch, F. Lalezari, P. Priestley, C. Shale, et al. 2021. “1133P Whole Genome Sequencing Can Classify Diagnostically Challenging Tumors.” Annals of Oncology 32 (September): S924–25. doi:10.1016/j.annonc.2021.08.775.